Dr Serguei Semenov

EMTensor GmbH

Dr. Semenov and his team have developed Electromagnetic Tomography for biomedical applications since the early 1990s at the Carolinas Medical Center, Charlotte, NC, USA, then at Keele University, School of Medicine, Staffordshire, UK. In 2012 Dr. Semenov with his partners incorporated EMTensor GmbH, located in Vienna, Austria, as a vehicle to further R&D and commercialize EMT technology. Brain imaging (primarily stroke detection) is an initial application of EMT under R&D of the Company.
Dr. Semenov is author and co-author of dozens of peer-reviewed publications, invited and keynote speaker at numerous events, recipient of grant awards (including NIH grants), author and co-author of 19 issued patents and 13 patent pending in the area of EMT.

For more information visit www.emtensor.com

dont miss

Electromagnetic tomography for brain imaging

Electromagnetic Tomography (EMT) is a novel imaging modality recently emerging into various clinical applications, including brain imaging. The fundamentals of electromagnetic tomography for biomedical imaging lays at the experimental facts that tissue dielectric properties (imaged by EMT) are sensitive to tissue blood and water content, level of blood oxygenation, acute ischemia infarction, malignancies, and others to be presented at the seminar. Further, results of pre-clinical studied and recent clinical study results will be presented. The seminar will also cover R&D of scanners applicable for human brain imaging.

www.emtensor.com

Dr Serguei Semenov will be speaking in the following theatre:

Keynote Theatre - Wednesday 11.45 - 12.15: Electromagnetic tomography for brain imaging

EVEN MORE SEMINARS

  • Prof Alan Perkins: Speaking at the Medical Imaging Convention

    Prof Alan Perkins
    University of Nottingham

    Optical-Gamma Camera Imaging in Nuclear Medicine

  • Dr Matthew Prime: Speaking at the Medical Imaging Convention

    Dr Matthew Prime
    Roche Diagnostics Information Solutions

    Personalized healthcare: Leveraging data to improve patient care through clinical decision support in oncology

  • Dr Fred Ushakov: Speaking at the Medical Imaging Convention

    Dr Fred Ushakov
    University College London Hospital & London School of Ultrasound

    Spina bifida: Early diagnosis at 11-13 weeks of pregnancy

  • Laura Allington: Speaking at the Medical Imaging Convention

    Laura Allington
    University College London Hospitals NHS Foundation Trust

    Operational challenges of planning a new NHS high energy proton service

  • Matthew Gardner: Speaking at the Medical Imaging Convention

    Matthew Gardner
    RRPPS, University Hospitals Birmingham NHS Foundation Trust

    Patient dosimetry audit for nuclear medicine and radiotherapy planning CT